Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2008
Published online before print July 31, 2008, doi: 10.1161/CIRCRESAHA.108.176339
A more recent version of this article appeared on September 12, 2008
This Article
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
103/6/654    most recent
CIRCRESAHA.108.176339v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Beyer, A. M.
Right arrow Articles by Sigmund, C. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Beyer, A. M.
Right arrow Articles by Sigmund, C. D.

Submitted on March 25, 2008
Revised on July 17, 2008
Accepted on July 23, 2008

Endothelium-Specific Interference With Peroxisome Proliferator Activated Receptor Gamma Causes Cerebral Vascular Dysfunction in Response to a High-Fat Diet

Andreas M. Beyer ; Willem J. de Lange ; Carmen M. Halabi ; Mary L. Modrick ; Henry L. Keen ; Frank M. Faraci ; and Curt D. Sigmund PhD*

From the Genetics Graduate Program (A.M.B., C.M.H.), the Department of Internal Medicine (W.J.d.L., M.L.M., H.L.K., F.M.F., C.D.S.), the Department of Pharmacology (F.M.F.), the Department of Molecular Physiology and Biophysics (C.D.S.), and the Center on Functional Genomics of Hypertension (F.M.F.), Cardiovascular Center, Roy J. and Lucille A. Carver College of Medicine, The University of Iowa, Iowa City, Iowa.

* To whom correspondence should be addressed. E-mail: curt-sigmund{at}uiowa.edu.

The ligand-activated transcription factor PPAR{gamma} is expressed in vascular endothelium where it exerts anti-inflammatory and antioxidant effects. However, its role in regulating vascular function remains undefined. We examined endothelial function in transgenic mice expressing dominant-negative mutants of peroxisome proliferator activated receptor gamma (PPAR{gamma}) under the control of an endothelial-specific promoter to test the hypothesis that endothelial PPAR{gamma} plays a protective role in the vasculature. Under baseline conditions, responses to the endothelium-dependent agonist acetylcholine were not affected in either aorta or the basilar artery in vitro. In response to feeding a high-fat diet for 12 weeks, acetylcholine produced dilation that was markedly impaired in the basilar artery of mice expressing dominant-negative mutants, but not in mice expressing wild-type PPAR{gamma} controlled by the same promoter. Unlike basilar artery, 12 weeks of a high-fat diet was not sufficient to cause endothelial dysfunction in the aorta of mice expressing dominant-negative PPAR{gamma}, although it became evident after 25 weeks. The responses to acetylcholine in basilar artery were restored to normal after treatment with a scavenger of superoxide. Baseline blood pressure was only slightly elevated in the transgenic mice, but the pressor response to angiotensin II was augmented. Thus, interference with PPAR{gamma} in the endothelium produces endothelial dysfunction in the cerebral circulation through a mechanism involving oxidative stress. Consistent with its role as a fatty acid sensor, these findings provide genetic evidence that endothelial PPAR{gamma} plays a critical role in protecting a range of blood vessels in response to a high-fat diet.


Key words: endothelium • oxidative stress • transcription • transgenic animals • vascular




This article has been cited by other articles:


Home page
Diabetes CareHome page
F.-I Hsieh, W.-C. Lo, H.-J. Lin, Y.-C. Hsieh, L.-M. Lien, C.-H. Bai, H.-P. Tseng, and H.-Y. Chiou
Significant Synergistic Effect of Peroxisome Proliferator-Activated Receptor {gamma} C-2821T and Diabetes on the Risk of Ischemic Stroke
Diabetes Care, November 1, 2009; 32(11): 2033 - 2035.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. M. Kleinhenz, D. J. Kleinhenz, S. You, J. D. Ritzenthaler, J. M. Hansen, D. R. Archer, R. L. Sutliff, and C. M. Hart
Disruption of endothelial peroxisome proliferator-activated receptor-{gamma} reduces vascular nitric oxide production
Am J Physiol Heart Circ Physiol, November 1, 2009; 297(5): H1647 - H1654.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
K. Tsukuda, M. Mogi, J. Iwanami, L.-J. Min, A. Sakata, F. Jing, M. Iwai, and M. Horiuchi
Cognitive Deficit in Amyloid-{beta}-Injected Mice Was Improved by Pretreatment With a Low Dose of Telmisartan Partly Because of Peroxisome Proliferator-Activated Receptor-{gamma} Activation
Hypertension, October 1, 2009; 54(4): 782 - 787.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
L. Chang, L. Villacorta, J. Zhang, M. T. Garcia-Barrio, K. Yang, M. Hamblin, S. E. Whitesall, L. G. D'Alecy, and Y. E. Chen
Vascular Smooth Muscle Cell-Selective Peroxisome Proliferator-Activated Receptor-{gamma} Deletion Leads to Hypotension
Circulation, April 28, 2009; 119(16): 2161 - 2169.
[Abstract] [Full Text] [PDF]